Related Experiment Video
Updated: Apr 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Tobias Wagner1, Peter Brand1, Thorsten Heinzel1
1Center for Molecular Biomedicine, Institute of Biochemistry and Biophysics, Department of Biochemistry, Friedrich Schiller University of Jena, Hans-Knöll-Str. 2, 07745 Jena, Germany.
Abstract:
Histone deacetylase 2 (HDAC2) regulates biological processes by deacetylation of histones and non-histone proteins. HDAC2 is overexpressed in numerous cancer types, suggesting general cancer-relevant functions of HDAC2. In human tumors the TP53 gene encoding p53 is frequently mutated and wild-type p53 is often disarmed. Molecular pathways inactivating wild-type p53 often remain to be defined and understood. Remarkably, current data link HDAC2 to the regulation of the tumor suppressor p53 by deacetylation and to the maintenance of genomic stability. Here, we summarize recent findings on HDAC2 overexpression in solid and hematopoietic cancers with a focus on mechanisms connecting HDAC2 and p53 in vitro and in vivo. In addition, we present an evidence-based model that integrates molecular pathways and feedback loops by which p53 and further transcription factors govern the expression and the ubiquitin-dependent proteasomal degradation of HDAC2 and of p53 itself. Understanding the interactions between p53 and HDAC2 might aid in the development of new therapeutic approaches against cancer.
Insights
Histone deacetylase 2 (HDAC2) is overexpressed in cancers and impacts the tumor suppressor p53. Understanding their interaction is key for developing new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Histone deacetylase 2 (HDAC2) regulates cellular processes via protein deacetylation.
- HDAC2 overexpression is common in various cancers, implicating it in cancer progression.
- TP53 gene mutations and p53 inactivation are frequent in human tumors, with incompletely understood mechanisms.
Purpose of the Study:
- To summarize recent findings on HDAC2 overexpression in cancer.
- To elucidate the mechanisms connecting HDAC2 and the tumor suppressor p53.
- To present a model of the interplay between p53 and HDAC2.
Main Methods:
- Literature review of in vitro and in vivo studies.
- Analysis of molecular pathways regulating HDAC2 and p53.
- Integration of feedback loops involving transcription factors.
Main Results:
- HDAC2 is linked to p53 regulation through deacetylation and maintenance of genomic stability.
- HDAC2 overexpression is observed in both solid and hematopoietic malignancies.
- A model is presented detailing how p53 and other factors regulate HDAC2 and p53 expression and degradation.
Conclusions:
- The interaction between p53 and HDAC2 is crucial in cancer biology.
- Understanding these molecular mechanisms can inform novel therapeutic strategies.
- Targeting the HDAC2-p53 axis may offer new avenues for cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Epigenetic Regulation
X-chromosome...

